Compare VEEV & AFRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VEEV | AFRM |
|---|---|---|
| Founded | 2007 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Business Services |
| Sector | Technology | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.3B | 28.3B |
| IPO Year | 2013 | 2020 |
| Metric | VEEV | AFRM |
|---|---|---|
| Price | $213.50 | $78.47 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 25 | 25 |
| Target Price | ★ $280.42 | $84.52 |
| AVG Volume (30 Days) | 1.3M | ★ 3.5M |
| Earning Date | 05-27-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 25.93 | ★ 108.98 |
| EPS | ★ 1.57 | 0.90 |
| Revenue | $1,104,081,000.00 | ★ $3,224,412,000.00 |
| Revenue This Year | $14.42 | $30.78 |
| Revenue Next Year | $12.17 | $23.95 |
| P/E Ratio | $134.94 | ★ $86.80 |
| Revenue Growth | 28.05 | ★ 38.80 |
| 52 Week Low | $148.05 | $42.10 |
| 52 Week High | $310.50 | $100.00 |
| Indicator | VEEV | AFRM |
|---|---|---|
| Relative Strength Index (RSI) | 67.22 | 56.68 |
| Support Level | $174.25 | $71.24 |
| Resistance Level | $227.37 | $79.10 |
| Average True Range (ATR) | 7.02 | 2.89 |
| MACD | 1.21 | 0.15 |
| Stochastic Oscillator | 93.98 | 82.53 |
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
Founded in 2012, Affirm is a market leader in the buy now, pay later space with around $36 billion in transaction volume in fiscal 2025. Affirm offers both zero-interest financing, which is merchant subsidized, and interest-bearing loans, which function as personal loans that are approved on a per-transaction basis. Over 70% of Affirm's transaction volume comes from its interest-bearing loans, which also constitute the majority of its revenue. Affirm primarily operates in the United States, which accounted for more than 95% of its revenue in 2025, but it has also expanded to Canada and the United Kingdom.